Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis
- PMID: 21441480
- PMCID: PMC3144040
- DOI: 10.1177/0022034511399284
Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis
Abstract
Oropharyngeal candidiasis (OPC), caused primarily by Candida albicans, is the most common oral infection in HIV(+) persons. Although Th1-type CD4(+) T cells are the predominant host defense mechanism against OPC, CD8(+) T cells and epithelial cells become important when blood CD4(+) T cells are reduced below a protective threshold during progression to AIDS. In an early cross-sectional study, OPC(+) tissue biopsied from HIV(+) persons had an accumulation of activated memory CD8(+) T cells at the oral epithelial-lamina propria interface, with reduced expression of the adhesion molecule E-cadherin, suggesting a protective role for CD8(+) T cells but a dysfunction in the mucosal migration of the cells. In a subsequent 1-year longitudinal study, OPC(-) patients with high oral Candida colonization (indicative of a preclinical OPC condition), had higher numbers of CD8(+) T cells distributed throughout the tissue, with normal E-cadherin expression. In OPC(+) patients, where lack of CD8(+) T cell migration was associated with reduced E-cadherin, subsequent evaluations following successful treatment of infection revealed normal E-cadherin expression and cellular distribution. Regarding epithelial cell responses, intact oral epithelial cells exhibit fungistatic activity via an acid-labile protein moiety. A proteomic analysis revealed that annexin A1 is a strong candidate for the effector moiety. The current hypothesis is that under reduced CD4(+) T cells, HIV(+) persons protected from OPC have CD8(+) T cells that migrate to the site of a preclinical infection under normal expression of E-cadherin, whereas those with OPC have a transient reduction in E-cadherin that prohibits CD8(+) T cells from migrating for effector function. Oral epithelial cells concomitantly function through annexin A1 to keep Candida in a commensal state but can easily be overwhelmed, thereby contributing to susceptibility to OPC.
Figures
Similar articles
-
Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.Adv Dent Res. 2006 Apr 1;19(1):80-4. doi: 10.1177/154407370601900116. Adv Dent Res. 2006. PMID: 16672555 Review.
-
CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.Oral Dis. 2012 Mar;18(2):153-61. doi: 10.1111/j.1601-0825.2011.01856.x. Epub 2011 Sep 30. Oral Dis. 2012. PMID: 21958417 Free PMC article.
-
Immunity to Candida.Oral Dis. 2002;8 Suppl 2:69-75. doi: 10.1034/j.1601-0825.2002.00015.x. Oral Dis. 2002. PMID: 12164664 Review.
-
Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.Infect Immun. 2003 Feb;71(2):956-63. doi: 10.1128/IAI.71.2.956-963.2003. Infect Immun. 2003. PMID: 12540578 Free PMC article.
-
Characterization of the immune status of CD8+ T cells in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal Candidiasis.Clin Vaccine Immunol. 2006 Jun;13(6):678-83. doi: 10.1128/CVI.00015-06. Clin Vaccine Immunol. 2006. PMID: 16760327 Free PMC article.
Cited by
-
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.Infect Immun. 2016 Sep 19;84(10):2724-39. doi: 10.1128/IAI.00469-16. Print 2016 Oct. Infect Immun. 2016. PMID: 27430274 Free PMC article. Review.
-
Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa.Front Immunol. 2019 Mar 8;10:426. doi: 10.3389/fimmu.2019.00426. eCollection 2019. Front Immunol. 2019. PMID: 30906299 Free PMC article. Review.
-
Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.Antimicrob Agents Chemother. 2015 Nov 23;60(2):881-9. doi: 10.1128/AAC.02624-15. Print 2016 Feb. Antimicrob Agents Chemother. 2015. PMID: 26596951 Free PMC article.
-
Immune status, and not HIV infection or exposure, drives the development of the oral microbiota.Sci Rep. 2020 Jul 2;10(1):10830. doi: 10.1038/s41598-020-67487-4. Sci Rep. 2020. PMID: 32616727 Free PMC article.
-
Distribution and antifungal susceptibility profiles of Candida species isolated from people living with HIV/AIDS in a public hospital in Goiânia, GO, Brazil.Braz J Microbiol. 2023 Mar;54(1):125-133. doi: 10.1007/s42770-022-00851-w. Epub 2022 Nov 12. Braz J Microbiol. 2023. PMID: 36371517 Free PMC article.
References
-
- Beno DW, Stover AG, Mathews HL. (1995). Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 154:5273-5281 - PubMed
-
- Calderone RA, editor. (2002). Candida and Candidiasis. Washington, DC: ASM Press
-
- Calderone RA, Fonzi WA. (2001). Virulence factors of Candida albicans. Trends Microbiol 9:327-335 - PubMed
-
- Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. (1999). In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180:448-453 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials